| Name | Title | Contact Details |
|---|
TalkCounsel is a legal marketplace that enables business owners, individuals, and startups to find, hire and collaborate with attorneys remotely without breaking the bank. We aim to make quality legal services more accessible and affordable for everyone. We believe that access to justice should be available to all, regardless of income or location. With TalkCounsel, you can get the legal help you need without sacrificing your budget.
Harbinger is a commercial electric vehicle (EV) company on a mission to transform an industry starving for innovation. Harbingers best-in-class team of EV, battery, and drivetrain experts have pooled their deep experience to support the growing demand for medium-duty EVs. Leveraging a foundation of proprietary, in-house developed vehicle technologies designed specifically for commercial vehicles, Harbinger is bringing a first-of-its-kind EV platform to market, priced for zero acquisition premium. Harbinger: familiar form, revolutionary foundation.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
With a history of over 25 years, Ceto has forged enduring partnerships with over 2,000 regional and community banks and credit unions nationwide, igniting their profitability and growth. Our unwavering commitment lies in empowering financial institutions with cutting-edge intelligence and transformative solutions, elevating shareholder value, and fostering thriving, prosperous communities. Discover more at ceto.com or dial 866.227.1361 to embark on a transformative journey.
Hoja is a business center dedicated in offering a bundle of services to businesses and individuals. Our offices are located in the capital city of Kosova in Prishtina. We aim to build and offer a bundle of services to businesses and individuals by delivering value and high quality solutions. Our commitment ranges from the beginning of a collaboration, to the extensive needs that follow through our partnerships. We must provide value, both for our company and our clients. We must meet or exceed all requirements in an efficient and cost effective manner. We must maintain a balance of proven techniques with the ability to be innovative . Our markets will include industrial, commercial, agricultural, regional and residential clients. Our company will be able to provide a package of services that will allow us to offer conception to completion efficiency.